Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Clinical and Experimental Nephrology|May 7, 2022
Relationships of hyperchloremia with hypertension and proteinuria in patients with chronic kidney diseaseAkira Takahashi, Kazuya Maeda, Kensuke Sasaki, et al.
Clinical Nephrology|April 28, 2018
Tocilizumab histologically improved AA renal amyloidosis in a patient with multicentric Castleman disease: A case reportYumi Yamada, Toshinori Ueno, Taisuke Irifuku, et al.
Clinical and Experimental Nephrology|February 26, 2018
pH after the first session of direct hemoperfusion with polymyxin B-immobilized fibers predicts mortality in patients with sepsis and septic shockAiko Okubo, Ayumu Nakashima, Shigehiro Doi, et al.
Plos One|March 10, 2017
Inhibition of H3K9 methyltransferase G9a ameliorates methylglyoxal-induced peritoneal fibrosisKazuya Maeda, Shigehiro Doi, Ayumu Nakashima, et al.
Clinical and Experimental Nephrology|December 9, 2016
Valproic acid attenuates renal fibrosis through the induction of autophagyKoichiro Kawaoka, Shigehiro Doi, Ayumu Nakashima, et al.
American Journal of Physiology. Renal Physiology|September 8, 2022
The hypoxia-inducible factor-α prolyl hydroxylase inhibitor FG4592 ameliorates renal fibrosis by inducing the H3K9 demethylase JMJD1ATakeshi Ike, Shigehiro Doi, Ayumu Nakashima, et al.
American Journal of Physiology. Renal Physiology|April 11, 2018
Na+-Cl- cotransporter-mediated chloride uptake contributes to hypertension and renal damage in aldosterone-infused ratsTakahiro Yamauchi, Shigehiro Doi, Ayumu Nakashima, et al.
Plos One|May 4, 2018
Inhibition of the H3K4 methyltransferase SET7/9 ameliorates peritoneal fibrosisRyo Tamura, Shigehiro Doi, Ayumu Nakashima, et al.
Pageof 8